No Data
Avidity Biosciences Insider Sold Shares Worth $2,121,045, According to a Recent SEC Filing
Michael F MacLean, Chief Financial Officer, on May 14, 2024, sold 75,000 shares in Avidity Biosciences (RNA) for $2,121,045. Following the Form 4 filing with the SEC, MacLean has control over a total
Avidity Biosciences(RNA.US) Officer Sells US$2.12 Million in Common Stock
$Avidity Biosciences(RNA.US)$ Officer MacLean Michael F sold 75,000 shares of common stock on May 14, 2024 at an average price of $28.2806 for a total value of $2.12 million.Source: Announcement What
Express News | Avidity Biosciences Announces Appointment of Simona Skerjanec to Board of Directors
Form 144 | Avidity Biosciences(RNA.US) Officer Proposes to Sell 1.95 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $Avidity Biosciences(RNA.US)$ Officer MICHAEL MACLEAN intends to sell 75,000 shares of its common stock on May 14, with a total market value of approximately $1.95 mill
Vicore Expands and Strengthens Its Board of Directors
STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 / Vicore Pharma Holding Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of
Avidity Biosciences: Strong Buy on Promising Trials and Solid Financials